Meeting
2022 ASCO Gastrointestinal Cancers Symposium
The impact of germline and somatic mutations in the homologous recombination repair pathway in pancreatic cancer patients who undergo perioperative chemotherapy.
Authors
Gudbjorg Jonsdottir
University of Iowa Hospitals and Clinics, Iowa City, IA
Gudbjorg Jonsdottir , Asgeir Thor Masson , Laura S. Jacobus , Michelle L. Churchman , Stephen B. Edge , Anne M. Noonan , Michael J. Cavnar , Susanna Varkey Ulahannan , Ibrahim Halil Halil Sahin , Carlos Hou Fai Chan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.602
Abstract #
602
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
The impact of HRD in patients with pancreatic adenocarcinoma undergoing surgical resection: An updated analysis.
First Author: Gudbjorg Jonsdottir
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh